SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
____________________________________________________

FORM 10-Q

þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended January 31, 2010

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
 
Commission File Number 0-02555
 
Exobox Technologies Corp.
 (Name of Small Business Issuer in its charter)

Nevada
88-0456274
(State or other jurisdiction of incorporation)
(I.R.S. Employer Identification No.)
   
2121 Sage Road, Suite 200, Houston, Texas
77056
(Address of principal executive offices)
(Zip code)

Securities registered under Section 12(g) of the Exchange Act:
Common Stock
(Title of class)

(Title of class)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files)   þ   Yes    o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  
 
Large accelerated filer o
Accelerated filer o
Non-accelerated filer o
Smaller reporting Company   þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes o No þ

As of March 17, 2010, 392,635,544 of the registrant's common stock were outstanding.

EXOBOX TECHNOLOGIES CORP.
FORM 10-Q FOR THE QUARTER ENDED JANUARY 31, 2010
 
INDEX
 
PART   I.  FINANCIAL INFORMATION
  Page
 
  No.
Item 1. Financial Statements
 
   
Balance Sheets as of January 31, 2010  and  July 31, 2009  (Unaudited).
3
   
Statements of Operations for the three months ended January 31, 2010 and 2009, for the six months ended January 31, 2010 and 2009 and for the period from October 21, 2002 (Inception) to January 31, 2010  (Unaudited).
4
   
Statements of Cash Flows for the six months ended January 31, 2010 and 2009  and for the period from October 21, 2002 (Inception) to January 31, 2010  (Unaudited).
5
   
 
Notes to the Financial Statements (Unaudited)
 
6
   
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
10
   
Item 3. Quantitative and Qualitative Disclosures about Market Risk
12
   
Item 4. Controls and Procedures
12
   
PART II. OTHER INFORMATION
 
   
Item 1. Legal Proceedings
12
   
Item 2. Recent Sales of Unregistered Securities
13
   
Item 3. Defaults Upon Senior Securities
13
   
Item 4. Submission of Matters to a Vote of Security Holders
13
   
Item 5. Other Information
13
   
Item 6. Exhibits
14
   
Signatures
15
 


EXOBOX TECHNOLOGIES CORP.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEETS
(Unaudited)

   
January 31, 2010
   
July 31, 2009
 
ASSETS
       
Current Assets:
       
Cash
    1,321       3  
Accounts Receivable
    13,144       -  
Other Current Assets
    11,194       8,561  
Total Current Assets
    25,659       8,564  
                 
Furniture, fixtures and equipment, net
    343,707       395,338  
Other Assets:
               
Patents, net
    -       1  
Intangibles, net
    13,452       6,568  
                 
TOTAL ASSETS
    382,818       410,471  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
               
Current Liabilities:
               
Accounts Payable
    516,993       432,621  
Accounts Payable-Stockholders
    65       2,594  
Accrued Liabilities
    1,951,923       314,964  
Advances from Stockholders
    700,437       875,081  
Note Payable
    50,000       30,000  
Secured Notes Payable
    90,000       -  
                 
Deferred Income
    -       1,400  
Total Current Liabilities
    3,309,418       1,656,660  
                 
TOTAL LIABILITIES
    3,309,418       1,656,660  
                 
STOCKHOLDERS' DEFICIT
               
Preferred stock:
               
Series A convertible preferred stock, $0.001 par, 2,500,000 shares authorized, 1,378 and 1,378 shares issued and outstanding as of January 31, 2010 and July 31, 2009, respectively
    1       1  
 Series E convertible preferred stock, $0.001 par, 0 and  0 shares issued and outstanding as of January 31, 2010 and July 31, 2009, respectively
    -       --  
Common stock, $0.001 par value, 500,000,000 shares authorized, 392,635,554
and 460,664,395 shares issued and outstanding at January 31, 2010 and July 31 2009, respectively
    392,635       460,664  
Additional paid-in capital
    16,693,377       14,481,168  
Deficit accumulated during development stage
    (20,012,613     (16,188,022 )
                 
Total stockholders' deficit
    (2,926,600 )     (1,246,189 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
    382,818       410,471  

See accompanying notes to the financial statements
-3-

EXOBOX TECHNOLOGIES CORP.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF OPERATIONS
For the Quarters Ended January 31, 2010 and 2009,
and the period from October 21, 2002 (Inception) to January 31, 2010
(Unaudited)

   
Three Months
Ended
January 31,
2010
   
Three
Months
Ended
January 31,
2009
   
Six Months
Ended
January 31,
2010
   
Six Months
Ended
January 31,
2009
   
Inception
(October 21,
2002)
to January 31,
2009
 
                               
Revenues
    10,520       -       14,420       -       14,420  
Cost Of Revenues
    6,162       -       15,219       -       29,876  
Net Revenue/Gross Loss
    4,358       -       (799 )             (15,456 )
                                         
 
General & Administrative
  698,907     179,816     1,852,263     338,562     6,530,440  
Depreciation and amortization
    30,468       26,431       59,248       47,216       187,584  
Professional Fees
    63,066       552,079       198,135       955,575       4,410,472  
Payroll Expenses
    1,429,763       482,694       1,703,057       794,164       7,583,205  
Loss on Disposal of Assets
    -       -       -       -       9,855  
Loss on Impairment of Assets
    -       -       -       -       50,591  
Research and Development
    14,580       11,110       35,674       11,110       1,226,757  
                                         
Total Operating Expenses
    2,236,784       1,252,130       3,848,377,       2,146,627       19,998,904  
                                         
Loss from Operations
    (2,232,426 )     (1,252,130     (3,849,176     (2,146,627     (20,014,360 )
                                         
Other Income (Expense):
                                       
Gain on Derivatives
                            -       100,000  
Gain  on sale of patent and impairment of patent
    (56,250 )             38,750               38,750  
Gain on Extinguishment of AP
    -               -               84,065  
Gain on Extinguishment of Note
    3,000               3,000       -       10,137  
Discontinued Operations-Net Loss on Oil and Gas Wells
    (22,009 )             (22,009             (22,009 )
Discontinued Operations-Gain on Disposition
    22,009               22,009               22,009  
Interest Income
    -       129       -       1,452       3,578  
Interest Expense
    (16,301       (412 )     (17,165 )     (1,037 )     (234,783 )
Total Other Income (Expenses)
    (69,578 )     (283       24,585       415       1,747  
                                         
Loss Before Income Taxes
    (2,302,004 )     (1,252,413 )     (3,824,591     (2,146,212     (20,012,613 )
                                         
Provision for Income Taxes
    -       -       -       -       -  
                                         
Net Loss
  (2,302,004   (1,252,413   (3,824,591     (2,146,212   (20,012,613 )
                                         
Basic and diluted
                                       
Net loss per common share-basic and diluted
  (0.00   (0.00   (0.00   (0.01        
                                         
Weighted average shares outstanding-basic and diluted
    471,229,176       402,447,715       421,239,740       400,646,350          

See accompanying notes to the financial statements
-4-

EXOBOX TECHNOLOGIES CORP.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CASH FLOWS
For the six months Ended January 31, 2010 and 2009,
and period from October 21, 2002 (Inception) to January 31, 2010
(Unaudited)

   
Six Months Ended January 31,
 
Six Months Ended January 31,
 
October 21, 2002 (Inception) to January 31,
   
2010
 
2009
 
2010
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net Loss
 
$
(3,824,591)
 
$
(2,146,212)
 
$
(20,012,613)
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Shares issued for services
   
1,688,368
   
549,307
   
5,390,622
Warrant issued for consulting services
   
-
   
-
   
446,660
Loss on disposal of assets
   
-
   
-
   
9,856
Loss on impairment of assets
   
-
   
-
   
50,591
Depreciation and amortization
   
59,248
   
47,216
   
187,585
Share-based compensation
   
6,112
   
13,192
   
2,902,889
(Gain) Loss on derivative
   
-
   
-
   
5,000
Gain on debt conversion
   
(3,000)
   
-
   
(10,137)
(Gain)Loss on accounts payable
   
-
   
-
   
(84,065)
(Gain)Loss on sale of patent
   
(38,750)
   
-
   
(38,750)
Contributed capital
   
12,911
   
-
   
75,433
Amortization of debt discount
   
-
   
-
   
80,000
Changes in operating assets and  liabilities
                 
Prepaid and other current assets
   
(2,633)
   
53,420
   
(11,194)
Accounts payable
   
84,372
   
309,945
   
636,916
Accounts receivable
   
(13,144)
   
-
   
(13,144)
Accrued expenses
   
1,636,959
   
72,785
   
3,705,090
Deferred income
   
(1,400)
   
-
   
-
Accounts payables to stockholders
   
11
   
-
   
2,605
NET CASH USED IN OPERATING ACTIVITIES
   
(395,537)
   
(1,100,347
)
 
(6,676,656 )
                   
CASH FLOW FROM INVESTING ACTIVITIES
                 
Proceeds from sale of patents
   
-
   
-
   
-
Proceeds from sale of property
   
-
         
-
Investment in patents
   
95,000
   
-
   
27,767
Investment in intangible assets
   
(6,283)
   
-
   
(22,283)
Investment in property and equipment
   
(8,217)
   
(206,159)
   
(466,715)
NET CASH USED IN INVESTING ACTIVITIES
   
80,500
   
(206,159)
   
(461,231)
                   
CASH FLOWS FROM FINANCING ACTIVITIES
                 
Proceeds from sale of stock
   
142,000
   
-
   
5,425,200
Advances from stockholders
   
115,355
   
543,000
   
1,543,936
Proceeds from warrants exercised
   
9,000
   
-
   
546,502
Repayment of advances from stockholders
   
-
   
-
   
(501,430)
Convertible Promissory Notes proceeds
   
30,000
   
-
   
210,000
Proceeds from third party debt, net
   
20,000
   
-
   
(85,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES
   
316,355
   
533,000
   
7,139,208
                   
NET CHANGE IN CASH AND CASH EQUIVALENTS
   
1,318
   
(763,506)
   
1,321
Cash and cash equivalents at beginning of period
   
3
   
767,338
   
-
Cash and cash equivalents at end of period
 
$
1,321
 
$
3,832
 
$
1,321
                   
SUPPLEMENTAL DISCLOSURES
                 
Cash paid for interest
 
$
1,695
 
$
1,037
     
Cash paid for income taxes
         
-
     
                   
NON-CASH TRANSACTIONS
                 
Conversion of Preferred Shares to Common Shares
   
-
   
2,078
     
Shares Returned and Cancelled
 
$
128,069
 
$
-
     
Acquisition of oil & gas wells – debt and stock issued
 
$
     5,867,361
           
Disposition of oil & gas wells – debt and stock canceled
 
$
5,867,361
           
Debt Forgiveness
 
$
202,539
           
Stock issued for patent buyback
 
$
56,250
           
Conversion of Note Payable to stock
 
$
27,000
           

See accompanying notes to the financial statement s
-5-

EXOBOX TECHNOLOGIES CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO THE FINANCIAL STATEMENTS
(Unaudited)

NOTE 1 – NATURE OF BUSINESS AND SUMMARY OF ACCOUNTING POLICIES

The accompanying unaudited interim financial statements of Exobox Technologies Corp., a Nevada corporation, have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in our latest Annual Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the most recent fiscal year, July 31, 2009, as reported in Form 10-K, have been omitted.

Certain prior quarter amounts have been reclassified to conform with the current quarter presentation.

Exobox is an enterprise and home user network and data security development company formed to capitalize upon the growing need for a modern, reliable, efficient, effective and proactive network and data security solutions.  Exobox is the parent company to its wholly-owned subsidiary, Exbx Energy, Inc., a Texas corporation (“Exbx Energy”) since its formation in October, 2009.

NOTE 2 - GOING CONCERN

From Inception to January 31, 2010, Exobox has accumulated losses of $20,012,613. The ability of Exobox to emerge from the development stage with respect to any planned principal business activity is dependent upon its success in raising additional equity or debt financing and/or attaining profitable operations. Management has plans to seek additional capital. There is no guarantee that Exobox will be able to complete any of the above objectives. These factors raise substantial doubt regarding Exobox's ability to continue as a going concern. Management has had difficulties in raising capital because of legacy issued which include past debt and current equity structure.

NOTE 3 – PATENTS

Patents are mainly comprised of legal services paid to a shareholder and patent application fees.  Exobox began amortizing these costs since the patents have been granted.  Patents were impaired as of July 31, 2009 for $50,591.

On September 15, 2009, Exobox sold its SOS Patents to Scott Copeland for $95,000.  On November 1, 2009, Copeland sold these SOS patents back to Exobox for 1,250,000 common shares valued at $56,250 and also a royalty of 3% of any net proceeds derived from the SOS technology.  Exobox recorded gain on sale of patent of $38,750.
 
  NOTE 4 – DEBT
 
In June 2009, Exobox issued an unsecured promissory note to RSA Corp by converting the $35,000 previously outstanding accounts payable balance.  The note bears interest of 0% per year and matured December 1, 2009.  The loans totaled to $31,400 which includes $1,400 in interest as of January 31, 2010.  On November 3, 2009, the Company received a demand for payment.  To date, no suit has been filed.

 In September 2009, Exobox borrowed $30,000 under convertible notes payable to two individuals.  These notes were paid on January 31, 2010 through the issuance of 1,000,000 common shares and warrants to purchase 990,000 common shares at $0.03 per share for a term of three years.  Exobox evaluated the terms of the notes in accordance w ith FASC 815 (formerly SFAS No. 133, “ Accounting for Derivative Instruments and Hedging Activities ”, and EITF Issue 00-19, “ Accounting for Derivative Financial Instruments to and Potentially Settled in a Company’s Own Stock”) .  Exobox determined that the convertible notes are not derivative instruments.  Exobox evaluated the conversion feature under FASC 470 (formerly EITF 98-5 and EITF 00-27) and determined that a beneficial conversion feature should be recognized and gave rise to a debt discount of $28,410.  There was a gain on the retirement of the note of $3,000 and the debt discount was eliminated.

In November, 2009, Mr. Scott Copeland agreed to forgive a $200,000 note and its related accrued interest which we recorded as $202,540 to additional paid in capital since Mr. Scott Copeland is a related party.

In December 2009 and January 2010, four individuals, including two members of management, loaned the company a total of $90,000 in exchange for 10% notes with a nine month maturity.  The notes are secured by the Company’s technology.  Upon payment of the notes, the security interest of the debtor in the technology will be released back to the Company.

On December 8, 2009, the company received a demand to repay Reginald Goodman $227, 301 ($210,400 principal and $16,970 in accrued interest).  To date, no suit has been filed.
-6-

On December 8, 2009, Mr. Kampa loaned the company $3,000 through a non-interest bearing promissory note which was due on January 31, 2010.  As of March 25, 2010, the note has not been paid.  The company intends to negotiate an extension on the note.

On December 9, 2009, an entity 25% owned by Mr. Wirtz and 50% owned by former management or board members loaned the company $20,000 through a 12% promissory note due on May 31, 2010.

NOTE 5 – STOCKHOLDERS’ EQUITY

Stock Issued for Services

During the six months ended January 31, 2010, we issued 47,189,752 common shares to consultants and employees pursuant to consulting and employment agreements with a value of $1,688,368.

Stock Issued for Cash

During the six months ended January 31, 2010, we issued 10,450,000 common shares for $142,000 in cash.

Stock Issued for Warrants Exercised

During the six months ended January 31, 2010, we issued 150,000 common shares in relation to warrants exercised for $9,000.

Stock Issued for Debt

During the six months ended January 31, 2010, we issued 1,000,000 common shares in relation to convertible note. (see Note 4 above)

Stock Issued for Patents

During the six months ended January 31, 2010, we issued 1,250,000 common shares valued at $56,250.  (see Note 3 above)

Stock Option, Stock Warrant and Stock Award Plan
  
OPTIONS

In the six months ended January 31, 2010, Exobox granted an employee an option to purchase 25,000 shares with exercise price of $0.25 a share. The shares were vested immediately.  During the six months ended January 31, 2010, 12,650,000 shares expired due to 90 days passing of the termination of employment of several option holders as call for in the 2007 Stock Option Plan.
 
The following assumptions were applied to value the options:
 
Expected volatility
   
174%- 243%
 
Term (years)
   
1.5 – 3
 
Risk-free interest rate
   
1.16% - 3.01%
 
Expected dividend yield
   
0%
 
 
Black-Scholes was applied to value the options and Exobox recognized $6,112 of stock based compensation expense for the six months ended January 31, 2010.  The remaining 75,000 unvested shares have an unrecognized value of $6,065.  The options intrinsic value is $0 as of January 31, 2010.
 
The status of the options as of January 31, 2010, is as follows:
 
   
Options
   
Weighted Average Exercise Price
 
Outstanding July 31, 2009
   
20,225,000
     
0.28
 
Granted
   
25,000
     
-
 
Expired
   
12,650,000
     
0.25
 
Exercised
   
-
     
-
 
Outstanding, January 31, 2010
   
7,600,000
   
$
0.35
 

Following is the details of options outstanding as of January 31, 2010:
 
Number of Common Stock Equivalents
 
Expiration Date
 
Remaining Contracted Life (Years)
   
Exercise Price
 
  25,000  
4/1/2012
   
2.17
     
0.25
 
  25,000  
4/1/2013
   
3.17
     
0.25
 
  25,000  
4/1/2014
   
4.17
     
0.25
 
  25,000  
4/1/2015
   
5.17
     
0.25
 
  2,500,000  
12/1/2013
   
3.83
     
0.15
 
  1,500,000  
12/1/2013
   
3.83
     
0.25
 
  1,500,000  
12/1/2013
   
3.83
     
0.40
 
  1,000,000  
12/1/2013
   
3.83
     
0.50
 
  1,000,000  
12/1/2013
   
3.83
     
0.75
 
  7,600,000        
3.82
     
0.35
 
-7-

The following is a summary of non-vested shares:
 
   
OPTIONS
 
Non-vested shares at July 31, 2009
    278,385  
Granted
    0  
Vested
    -  
Expired
    (203,385 )
Exercised
    -  
Non-vested shares at January 31, 2010
    75,000  
 
WARRANTS
 
At January 31, 2010, we had outstanding and exercisable warrants to purchase an aggregate of 15,844,284 shares of common stock with an intrinsic value of $0.  The weighted average remaining life is 1.73 years and the weighted average price per share is $0.42 per share.
 
The status of the warrants as of January 31, 2010, is as follows:
 
Warrants Outstanding and Exercisable
 
Warrants
   
Weighted Average Exercise Price
 
Outstanding, July 31, 2009
   
15,994,284
   
$
0.47
 
Granted
   
-
     
-
 
Expired
   
-
     
-
 
Exercised
   
(150,000)
     
  (0.06)
 
Outstanding, January 31, 2010
   
15,844,284
   
$
0.41
 
 
Following is the details of warrants outstanding as of January 31, 2010:
 
Number of Common Stock Equivalents
 
Expiration Date
 
Remaining Contracted Life (Years)
   
Exercise Price
 
  2,902,500  
10/31/2010
   
0.75
   
$
0.20
 
  50,000  
7/31/2011
   
1.50
   
$
0.25
 
  5,400,000  
12/31/2011
   
1.67
   
$
1.00
 
  1,600,000  
4/30/2012
   
2.00
   
$
0.03
 
  825,000  
6/1/2012
   
2.08
   
$
0.03
 
  2,075,000  
6/4/2012
   
2.08
   
$
0.03
 
  83,333  
6/12/2012
   
2.08
   
$
0.03
 
  1,408,451  
6/29/2012
   
2.17
   
$
0.03
 
  1,500,000  
9/24/2012
   
2.42
   
$
0.30
 
 
NOTE 6 – COMMITMENTS AND CONTINGENCIES

On January 22, 2010, an attorney representing former employee Gary Leibowitz sent the Company a demand letter asking the company pay him $640,000 in termination damages as called for in his employment agreement, $56,532.47 in compensation not paid and $1,079.37 in reimbursable expenses. In addition, a Notice of Default and demand letter was received demanding payment of a total of $16,551.13 ($15,987.63 promissory note and $563.50 of accrued interest) be made or Mr. Leibowitz would file suit.  The company intends to negotiate a settlement with Mr. Leibowitz on these demands. As of January 31, 2010, the past due loan and accrued interest were included part of the advances from stockholder.
-8-

On November 25, 2009, former employee Theodore Ernst filed suit in the 434 th District Court of Fort Bend County, Texas claiming unspecified damages.  On January 11, 2010, Exobox through its attorneys filed a motion to transfer venue, an application to compel arbitration and answered the Plaintiff’s petition.  The company intends to vigorously pursue defense of this action.

The company has yet accrued for any loss associated with these lawsuits due to too early to access the outcome.

NOTE 7 – OIL AND GAS PROPERTIES
  
On October 22, 2009, Exobox Technologies Corp. purchased 17 oil & gas wells located in Ohio from a private company for $5.9 million, which includes:
 
 
·
$3.0 million in total existing debt.
 
·
$1.5 million 5-year, 7.5% convertible note.
 
·
1,163,000 shares of Series E Convertible Preferred Stock, valued at $974,286.
 
·
3,000,000 common shares valued at $120,000.
 
·
$273,075 assumed asset retirement obligation

On January 13, 2010, Exobox and the seller mutually agreed to rescind the transaction, with cancelation of all obligations and securities issued.

A summary of the well income and expenses during the ownership period is as follows:

10/22/2009 to 1/13/2010
     
       
Revenue – sales of oil & gas
  $ 81,031  
EXPENSES
       
Depletion Expense
    21,282  
Expenses of Wells
    53,633  
Interest on $1.5m Note
    28,125  
Total Expenses
    103,040  
         
Net Income on Wells
  $ (22,009 )
 
NOTE 8- SUBSEQUENT EVENTS

On March 19, 2010, two of the four individuals who had previously loaned the company a total of $90,000 in exchange for a 10% promissory note with a nine month maturity, loaned the company an additional $25,000 and $4,000 in exchange for a 10% promissory notes with a nine month maturity.  These notes are secured by the Company’s technology.  Upon payment of the notes, the security interest of the debtor in the technology is released back to the Company.  The notes now total $119,000.

-9-

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This report on Form 10-Q contains forward-looking statements that relate to the Company's expectations regarding future events or future financial performance. Any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "intend", "believe," "estimate," "predict," "potential" or "continue," or the negative of such terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we, nor any other entity, assume responsibility for the accuracy and completeness of the forward-looking statements. We are under no obligation to update any of the forward-looking statements after the filing of this Form 10-Q to conform such statements to actual results or to changes in our expectations.

The following discussion should be read in conjunction with our condensed consolidated financial statements, related notes and the other financial information appearing elsewhere in this Form 10-Q. Readers are also urged to carefully review and consider the various disclosures made by us, which attempt to advise interested parties of the factors which affect our business, including without limitation, the disclosures made under Item 1A. Risk Factors.  The risk factors below supplement and should be read in conjunction with “ Risk Factors” under Item I in our Annual Report on Form 10-K for the fiscal year ended July 31, 2009.

Overview

Exobox Technologies Corp. develops and delivers information risk management and security software solutions that help organizations protect and recover their most valuable information assets. We are committed to our vision of creating a more secure environment for the information-centric community through the development of new technologies and security services.  This information-centric community is primarily comprised of companies that must abide by Governance, Risk and Compliance (GRC) policies - Fortune 500 public companies; the secondary target audience are those companies with valuable at-risk information, which includes financial services providers, healthcare providers and high-technology providers.

Information follows a typical path, or lifecycle:  creation, distribution, storage, copying, transformation, and disposal.  Throughout this data lifecycle, an organization’s information or intellectual property is at risk to exposure of being in the wrong hands or in the wrong place.  Nearly every organization has been exploited through data leaks. Intellectual property, financial information, confidential client lists, customer, patient and employee data . . . it is all at risk of exposure from both internal and external threats. The biggest contributors to information security risks are the open exchange of information through the Internet, especially via web 2.0 applications such as social-networking sites, video-sharing sites and blogs, the rapid growth of a mobile workforce, the termination of employment, the lack of understanding that information is confidential – just to name a few.  In fact, the market is so concerned about these issues that security software revenue is expected to exceed $13.1 billion by 2012 or a compound average growth rate (CAGR) of 10.5% by 2012 according to Gartner.

Recently, we have achieved several key milestones:
 
 
·
We released ExoDetect™ at the end of June 2009.  This first product is an affordable, software-as-a-service (SaaS) data leak detection (DLD) software solution that discovers and rates the risk of unauthorized “data in the wild.”  ExoDetect™ reports on the knowledge needed to tighten an organization’s data leak prevention (DLP) controls, while providing the first step in mitigating the financial and legal risks associated with stolen or misappropriated confidential information.  ExoDetect ™ performs scans for compromised data on any exposed area in the Internet Cloud; classifies the discovered information according to confidence and severity ratings; and captures the forensic evidence needed to address the breach, including litigation or prosecution. We have an ongoing process of updating and refining the ExoDetect™ product and have released the latest version 1.8 during the quarter.

 
·
The Company is focused on marketing to its clients its current products, ExoDetect™ and ExoWatch™ and developing its other proprietary technology.
 
The purchase of the oil & gas assets occurred under the prior CEO of the company.   Exobox’s current management believes that these assets had limited value and were not a good fit for the company as current management’s priority is software development.  Therefore, on January 13, 2010, Exobox and SPQR entered into a rescission agreement to unwind the October 22, 2009 agreement. In addition, Exobox and SPQR have agreed that both have no further rights, entitlements, liabilities or obligations with respect to the purchase and sale agreement and each party expressly releases the other with respect to any claims.
 
Exobox was founded in 2002 and, in conjunction with becoming a publicly-traded company in September 2005, merged with a successor Nevada corporation which was originally incorporated in 1999.
 
-10-

Results of Operations

Three Months Ended January 31, 2010 Compared to Three Months Ended January 31, 2009

Net Sales . Sales during the quarter ended January 31, 2010, were $10,520 compared to $0 for the quarter ended January 31, 2009.   These are some of the first sales for the company as the company brought its first product, ExoDetect™ to market earlier this year.

Research and Software Development Expenses . Research and software development expenses consist primarily of compensation and related costs for personnel responsible for the research and development of new products and services, and in the future will include those costs and expenses related to significant improvements to existing products and services. We have expensed research and development costs as they have been incurred. We had research and development expenses of $14,580 for the three months ended January 31, 2010 as compared to $0 incurred in the same period of 2009. The increased research and development expenses in 2010 relate to the costs of developing and maintaining ExoDetect™.

Sales and Marketing Expenses . Sales and marketing expenses consist primarily of compensation and related costs for personnel engaged in customer service, sales, and sales support functions, as well as advertising and promotional expenditures. We had sales and marketing expenses of $0 for the three months ended January 31, 2010 as compared to $ 0 incurred in the same period of 2009.  We expect to incur costs in the third quarter of 2010 as we are currently marketing the ExoDetect™ product.

General and Administrative Expenses (“G&A”) .   General and administrative expenses consist primarily of compensation and related costs for personnel and facilities related to our finance, human resources, facilities, information technology and legal organizations, and fees for professional services. Professional services are principally comprised of outside legal, audit, information technology consulting, general business consulting and outsourcing services. G&A expenses for the three months ended January 31, 2010 as compared to 2009 increased from $179,816 to $698,907. The increase was primarily due to increased services contracted for outside the company.

Payroll epxense .   Payroll expenses consist primarily of compensation and related costs for our current officiers and ex-emploees. Payroll expense for the three months ended January 31, 2010 as compared to 2009 increased from $482,694 to $1,429,763. The increase was primarily due to termination of several key employees and the termination payments due them under their employment agreements.

Net Loss .  Net loss for the three months ended January 31, 2010 and 2009 was $2,302,004 and $1,252,413, respectively. The increased loss was primarily due to termination of several key employees and the termination payments due them under their employment agreements and additional consulting fees.

Six Months Ended January 31, 2010 Compared to Six Months Ended January 31, 2009

Net Sales . Sales during the six months ended January 31, 2010, were $14,420 compared to $0 for the quarter ended January 31, 2009.   These are some of the first sales for the company as the company brought its first product, ExoDetect™ to market earlier this year.

Research and Software Development Expenses . Research and development expenses consist primarily of compensation and related costs for personnel responsible for the research and development of new products and services, and in the future will include those costs and expenses related to significant improvements to existing products and services. We have expensed research and development costs as they have been incurred. We had research and development expenses of $35,674 for the six months ended January 31, 2010 as compared to $11,110 incurred in the same period of 2009. The increased research and development expenses in 2009 relate to the costs of developing and maintaining ExoDetect™.

Sales and Marketing Expenses . Sales and marketing expenses consist primarily of compensation and related costs for personnel engaged in customer service, sales, and sales support functions, as well as advertising and promotional expenditures. In preparation for the upcoming release of our first product, ExoDetect™, we had sales and marketing expenses of $0 for the six months ended January 31, 2010 as compared to $ 0 incurred in the same period of 2009. We expect to incur costs in the third quarter of 2010 as we are currently marketing the ExoDetect™ product.

General and Administrative Expenses (“G&A”) .   General and administrative expenses consist primarily of compensation and related costs for personnel and facilities related to our finance, human resources, facilities, information technology and legal organizations, and fees for professional services. Professional services are principally comprised of outside legal, audit, information technology consulting, general business consulting and outsourcing services. G&A expenses for the six months ended January 31, 2010 as compared to 2009 increased to $1,852,263 from $338,562. The decrease was primarily due to increased services contracted outside the company.

Payroll expense .   Payroll expenses consist primarily of compensation and related costs for our current officiers and ex-emploees. Payroll expense for the six months ended January 31, 2010 as compared to 2009 increased from $794,164 to $1,703,057. The increase was primarily due to termination of several key employees and the termination payments due them under their employment agreements.

Net Loss .  Net loss for the six months ended January 31, 2010 and 2009 was $3,824,591 and $2,146,647, respectively. The increased loss was primarily due to termination of several key employees and the termination payments due them under their employment agreements.
-11-

Liquidity and Capital Resources

As of January 31, 2010, we had a working capital deficit of $3,283,759.  Our current liquidity position does not allow us to meet our nominal working capital need which has required us to leverage off our vendors and seek loans from certain shareholders. Historically, our working capital resulted from best efforts equity financing and shareholder loans. During the six months ended January 31, 2010, we borrowed $110,000 from certain shareholders on a short term basis.  To date, we have repaid $531,430 of the Company's total indebtedness, although it should be expected that we will borrow additional amounts in the future.   It is likely we will have to issue additional shares of our common stock in the future in an attempt to conserve cash. We will need to obtain working capital of at least $3,000,000 to fund our minimum operating expenses for the twelve months.  In order to fund our full product development, including marketing and testing, we will need to raise at least an additional $3,000,000 to $6,000,000.  We have no external credit or debt facilities in place to provide financing. We will be reliant upon best efforts debt or equity financing to provide necessary working capital.  Accordingly, there can be no assurance we will be able obtain necessary funding to meet working capital requirements, the failure of which will result in our curtailing operations and/or selling assets. Management has had difficulties in raising capital because of legacy issues which include past debt and current equity structure.

Off-Balance Sheet Arrangements

None.

Contractual Commitments

None.
 
ITEM 3.
QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

We have carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (the "CEO") and our Chief Financial Officer (the "CFO"), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Act")) as of the end of the fiscal quarter covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures are not effective in providing reasonable assurance that (a) the information required to be disclosed by us in the reports that we file or submit under the Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and (b) such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Specifically, our independent auditor identified weaknesses in our disclosure controls related to valuing and accounting for share-based payments, derivative financial instruments and accrued expenses. We plan to remediate this deficiency in disclosure controls by increasing the supervision and training of accounting employees.

There has been no change in our internal control over financial reporting during the quarter ended January 31, 2010, covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting

PART II – OTHER INFORMATION

ITEM 1.
LEGAL PROCEEDINGS

On November 25, 2009, former employee Theodore Ernst filed suit in the 434 th District Court of Fort Bend County, Texas claiming unspecified damages.  On January 11, 2010, Exobox through its attorneys filed a motion to transfer venue, an application to compel arbitration and answered the Plaintiff’s petition.  The company intends to vigorously pursue defense of this action.

On January 22, 2010, an attorney representing former employee Gary Leibowitz sent the Company a demand letter asking the company pay him $640,000 in termination damages as called for in his employment agreement, $56,532.47 in compensation not paid and $1,079.37 in reimbursable expenses. In addition, a Notice of Default and demand letter was received demanding payment of a total of $16,551.13 ($15,987.63 promissory note and $563.50 of accrued interest) be made or Mr. Leibowitz would file suit.  The company intends to negotiate a settlement with Mr. Leibowitz on these demands.

We know of no other material, active or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

We will vigorously defend ourselves in these lawsuits.  We believe that any of these matters could, individually or in the aggregate, have a material adverse effect on our business or financial condition.  We cannot give assurance, however, that one or more of these lawsuits will not have a material adverse effect on our results of operations for the period in which they are resolved.
-12-


ITEM 1A.
RISK FACTORS

Certain Factors that May Affect Future Performance

The risk factors below supplement and should be read in conjunction with “ Risk Factors” under Item I in our Annual Report on Form 10-K for the fiscal year ended July 31, 2009.

We have a limited operating history with significant losses and expect losses to continue for the foreseeable future.
 
We have incurred annual operating losses since our inception. As a result, at January 31, 2010, we had an accumulated deficit of $20,012,613 We had gross revenues of $14,420 for the six months ended January 31, 2010, and a loss from operations of $3,824,591. As we pursue our business plan, we expect our operating expenses to increase significantly, especially in the areas of sales and marketing. As a result, we expect continued losses in fiscal 2010 and thereafter.

We may not be able to meet our current and future liabilities and remain in operation until we receive additional capital .

As of January 31, 2010, we have current assets of $25,659 and current liabilities of $3,309,418.   Our current liquidity position only allows us to meet nominal working capital needs.  We will need $3,000,000 to meet our working capital needs through fiscal 2010.  Any failure to obtain such financing could force us to abandon or curtail our operations.

Our auditor has substantial doubts as to our ability to continue as a going concern.

Our auditor's quarterly report as of January 31, 2010 expresses an opinion that substantial doubt exists as to whether we can continue as an ongoing business.  Because we do not have sufficient capital, we may be required to suspend or cease the implementation of our business plans within 12 months. Because we have been issued an opinion by its auditors that substantial doubt exists as to whether we can continue as a going concern, it may be more difficult for us to attract investors.  Our future is dependent upon our ability to obtain financing and upon future profitable operations from the sale of our products.

ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES

Set forth below is certain information concerning issuances of common stock that were not registered under the Securities Act of 1933 (“Securities Act”) that occurred in the second quarter of fiscal 2010.

On November 15, 2009, December 15, 2009 and January 15, 2010 we issued a total of 1,385,251 shares of common stock to Mr. Dillon (1,154,376 shares) and Mr. Wirtz (230,875, shares) in accordance with the terms of their separation agreements.  As part of his employment agreement Mr. Wirtz agreed to forego the December 2009 through April 2010 payments called for in his May 6, 2009 Termination Agreement as long as he is an employee of the Company.

In November 2009, 1,000,000 common shares were issued to Mr. Kampa as part of his employment agreement.  The shares were valued at $45,000 on the date of issuance.

In November 2009, December 2009 and January 2010, the Company granted 15,250,000 shares of common stock to consultants for services performed .  The shares were valued at $533,000 on the date of issuance.

In November 2009, 1,500,000 common shares were sold to an entity 25% owned by Mr. Wirtz and 50% owned by former management or board members for $30,000 in cash proceeds to the company.
 
In November , 2009, 1,250,000 common shares were issued to Mr. Copeland to buy back patents that the Company had previously sold.  The shares were valued at $56,250 on the date of issuance.

In January 2010, 1,000,000 common shares were issued to two unaffiliated third parties to pay off $30,000 in convertible debt.

The issuances referenced above were consummated pursuant to Section 4(2) of the Securities Act and the rules and regulations promulgated thereunder on the basis that such transactions did not involve a public offering and the offerees were sophisticated, accredited investors with access to the kind of information that registration would provide. The recipients of these securities represented their intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the share certificates and other instruments issued in such transactions. No sales commissions were paid in connection with these issuances listed above.
 
 
ITEM 3.
 
 
DEFAULTS UPON SENIOR SECURITIES

None.
 
ITEM 4.
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

 
 
ITEM 5.
 
 
OTHER INFORMATION

On March 30, 2010, Exobox was granted its first patent relating to its Secure Environmentalization software.

-13-

ITEM 6. EXHIBITS

 
(a)
Exhibits

EXHIBIT NUMBER
DESCRIPTION OF EXHIBIT
31.1
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



-14-

EXOBOX TECHNOLOGIES CORP.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf of the undersigned thereunto duly authorized.

EXOBOX TECHNOLOGIES CORP.


Dated: March 30, 2010
By:  /s/ Richard J. Kampa
 
Richard J. Kampa
 
Chief Executive Officer and Director
 
(Principal Executive Officer)

Dated: March 30, 2010
By: /s/ Michael G. Wirtz
 
Michael G. Wirtz
 
Chief Financial Officer
 
(Principal Financial and Accounting Officer)
 

 

 

-15-

Exobox Technologies (CE) (USOTC:EXBX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Exobox Technologies (CE) 차트를 더 보려면 여기를 클릭.
Exobox Technologies (CE) (USOTC:EXBX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Exobox Technologies (CE) 차트를 더 보려면 여기를 클릭.